NeoBiocon partners with Novartis
To offer Vildagliptin for diabetics in the UAE NeoBiocon, a collaboration between Asia’s leading biopharmaceuticals company Biocon and Dr BR Shetty, Chairman of the UAE-based Neopharma, has partnered...
View ArticleClik here to view.
Sensex, Nifty to make flat-to-cautious start on GST woes; Aurobindo Pharma,...
The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on Thursday tracking SGX Nifty (Photo: Reuters) The BSE Sensex and NSE Nifty are likely to open on a soft-to-cautious note on...
View ArticleClik here to view.
Biocon share price gains as its arm NeoBiocon partners with Novartis
Biocon Chairperson and Managing Director Kiran Mazumdar-Shaw. NeoBiocon, a collaboration between Biocon Ltd and BR Shetty led UAE-based Neopharma, has partnered with Novartis Middle East FZE to market...
View ArticleClik here to view.
Biocon introduces therapy for treatment of Hepatitis C in India
In pic: Kiran Mazumdar-Shaw, chairperson and MD, Biocon. Biocon’s CIMIVIR-L will be made available to patients in India at a a fraction of the global cost of the innovator brand. The cost pf a 12-week...
View ArticleClik here to view.
Biocon shares fall post Q3 results, Syngene International gains over 7%
Biocon shares gained over 2% in the morning trade on Friday after the company announced 13.27% rise in its consolidated net profit figures to Rs 103 crore for the quarter ended Dec 2015. (Express...
View ArticleBiocon receives first generic formulation approval in EU
The approval will enable the company to address $1.2 billion opportunity, starting FY17 Biocon has received European approvals for its Rosuvastatin Calcium 5 mg, 10 mg, 20 mg and 40 mg tablets, a...
View ArticleBiocon in co-development and commercialisation agreement with Lab PiSA
The collaboration is part of Biocon’s strategy to address the large demand for generic rh-insulin in the US Biocon’s wholly owned subsidiary Biocon SA has entered into an agreement with Laboratorios...
View ArticleBiocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17 Biocon announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved its biosimilar Insulin Glargine. This is a significant...
View ArticleIn a first, Biocon insulin gets Japan nod
Bio-pharma major Biocon on Monday became the first Indian company to receive regulatory approval for a biosimilar insulin in Japan. This approval will enable the company to export Glargine, a...
View ArticleClik here to view.
Maruti Suzuki, HCL Tech, Yes Bank among 8 stocks that trended in Thursday’s...
Maruti Suzuki shares closed 2.94 per cent down at Rs 3748.45 after Japense yen soared almost 3 per cent against the dollar and euro as the Bank of Japan opted out of any further moves to ease policy....
View ArticleBiocon to invest Rs 1,060 crores in Bengaluru plant
The facility is expected to generate at least 750 jobs immediately Biocon plans to set up a new manufacturing facility near its existing campus at an investment of Rs 1,060 crores in Bangalore. The...
View ArticleClik here to view.
Biocon shares hit 52-week high, here is why
Biocon shares surged after global pharma major Mylan Inc, and the Indian pharma company confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, in...
View ArticleMylan and Biocon to present phase-III trastuzumab biosimilar data at ASCO...
HERITAGE study shows comparable efficacy, safety and immunogenicity to branded trastuzumab in HER2-positive metastatic breast cancer patients Mylan NV and Biocon have announced the presentation of data...
View ArticleBiocon expands its strategic partnership with CytoSorbents
Biocon will now have the exclusive, region-wide rights to distribute CytoSorb for all critical care applications in the ICU as well as cardiac surgery applications Biocon and US – based CytoSorbents...
View ArticleBiocon, Sun Pharma awarded for innovation
Study shows high tech engineering, pharma as front runners of innovation in India
View ArticleBiocon posts Rs 779 crore revenue in Q3 FY15
Research services delivers 20 per cent growth
View ArticleBiotech start ups get govt-backed equity fund
The BIRAC AcE Fund aims to accelerate growth of biotech startups
View ArticleKiran Mazumdar-Shaw honoured by Federation University Australia
Appointed as an ambassador of the university for a three-year term
View ArticleABLE elects new office bearers
To focus on improved strategies to catapult the industry to new heights The executive council of the Association of Biotechnology Led Enterprises (ABLE) has elected Dr Kiran Mazumdar Shaw, Chairman and...
View ArticleBiocon recognised for outstanding contribution to public health by WHO – India
Biocon's integrated healthcare initiatives is constantly engaged in improving the quality of life of several thousand communities in India
View ArticleBiocon Foundation wins ‘WHO –India Public Health Champion Award 2015’
Biocon recognised for outstanding contribution to public health by WHO – India
View ArticleBiocon receives approval for Insulin Glargine in Mexico through its partner...
The combined market for Insulin Glargine in Mexico is estimated to be in excess of $40 million
View ArticleABLE elects new office bearers
To focus on improved strategies to catapult the industry to new heights
View ArticleBiocon may sell 11% in Syngene IPO
Biocon on Tuesday said it would sell up to 11% in its contract research arm Syngene in the upcoming IPO.
View ArticleSyngene seeks approval for IPO, files DRHP
Offer allows Biocon to monetise its shareholding in Syngene
View ArticleBiocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth
View ArticleBiocon Q4 net up 78% on Syngene share sale
For FY15, Biocon reported a net profit of Rs 497 crore, recording growth of 20% over FY14. Revenue rose 7% to Rs 3,143 crore.
View ArticleBiocon-Mylan programmes make clinical progress
PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has made clinical progress in its partnered programmes with Mylan, which...
View ArticleKiran Mazumdar-Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India based business leader featuring on the list
View ArticleKiran Mazumdar Shaw ranked No. 2 in Global ‘Medicine Maker Power List’ 2015
She is the only India-based business leader featuring on the list
View ArticleSyngene International gets FIPB approval
Foreign investment limit raised to 44 per cent
View ArticleSyngene International gets RoC approval for its RHP
The price band for the offer has been fixed between Rs 240 and Rs. 250 per equity share of Rs 10 each
View ArticleBiocon to enter developed markets with biosimilar products in 3 years
Biocon’s biosimilar strategy is playing out well and the company is set to enter developed or regulated markets with a basket of biosimilar products in next three years.
View ArticleHold Biocon; Q1 profit weak excluding one-off gain: HSBC
Biocon reported Q1FY16 net profit Rs 12,620 crore.
View ArticleSyngene International IPO oversubscribed 31 times
The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene Syngene International’s (Syngene) Initial Public Offering (IPO) has been oversubscribed 31 times based on the...
View ArticleStocks in focus today: Adani Enterprises, DLF, Biocon and more
DLF stocks will be in focus as the company raised Rs 375 crore through non-convertible debentures (NCDs) as a part of its strategy to boost internal cash flows.
View ArticleSyngene to spend $100 m on new plant at Mangalore SEZ
Syngene International, a contract research arm of biotech major Biocon, has firmed up plans to diversify into contract manufacturing.
View ArticleBiocon inaugurates devices facility for insulin portfolio in Bangalore
The company also launches Basalog One, a ready to use insulin glargine disposable pen, for better blood sugar management Biocon has inaugurated a world class facility for manufacturing new generation,...
View ArticleBiocon share price gains on reporting 3-fold jump in Q2 consolidated net profit
Biocon share price gained as much as 1.87 per cent in the early trade on Wednesday after the biotechnology major on Tuesday after market hours reported an over three-fold jump in its consolidated net...
View ArticleBiocon share price hits fresh record high as Itolizumab drug gets DCGI nod...
Biocon share price touched a 52-week low of Rs 211.30 apiece in August 2019, since then the stock price has zoomed 115.33 per cent, doubling the investors' wealth in less than a year
View ArticleHCL Tech’s Roshini Nadar India’s richest women in 2020; check 10 richest...
HCL Technologies’ Chairperson Roshini Nadar Malhotra topped the Kotak Wealth Hurun Wealthy Women 2020 list, with total wealth of Rs 54,850 crore
View ArticleStocks in focus: Wipro, PNB, HDFC Bank, Biocon, AU Small Finance Bank, ICICI...
Nifty futures were trading 35 points or 0.25 per cent up at 14,005, suggesting a record high opening for BSE Sensex and Nifty 50 in today's session
View ArticleStocks in focus today: TCS, Vodafone Idea, State Bank of India, Tata Power,...
Nifty futures were trading 32.50 points up at 14,287.50 on Singaporean Exchange, suggesting a gap-up start for BSE Sensex and Nifty 50 on Friday
View ArticlePharma shares to continue surging despite rich valuations; HSBC lists top...
Even after pharma stocks witnessed a massive bull run in 2020 and valuations seem quite rich at this juncture, global investment bank HSBC expects the momentum to continue.
View ArticleInfosys, Indian Oil, Adani Green, Bosch, HPCL, Biocon, JK Lakshmi Cement,...
Domestic equity market benchmarks BSE Sensex and Nifty 50 were eyeing a positive start on Thursday after markets took a breather in the previous session
View Article
